1. 2109 Anti-EGFR or Bevacizumab in first line treatment of RAS wild type metastatic colorectal neoplasm (RwtMCRC): pooled analysis of randomized clincal trials. (September 2015) Authors: Tamburini, E.; Gianni, L.; Pasini, G.; Papi, M.; Stocchi, L.; Rudnas, B.; Affatato, A.; Drudi, F.; Nicoletti, S.; Santelmo, C.; Ridolfi, C.; Fantini, M.; Tassinari, D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗